STAGE II NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE II NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE II NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer combo therapy shows promise in early trial
Disease control CompletedThis early-phase study tested the safety and best dose of adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation for people with stage II to IIIB non-small cell lung cancer. The goal was to see if this combination could be given safely and to find any …
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 17, 2026 07:28 UTC
-
New combo therapy shows promise for hard-to-treat lung cancer
Disease control CompletedThis study tested a combination of a cancer vaccine (TG4010) and an immunotherapy drug (nivolumab) in 13 people with advanced non-small cell lung cancer who had already received other treatments. The goal was to see if the combination could shrink tumors or stop them from growing…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC